EMCDDA Home
  • EN
Search

Estonia

For a short overview of drug-related research in Estonia, visit the Country overviews. For a more comprehensive overview of drug-related research in the European countries, download our Selected issue on drug-related research. The Estonian National reports are available here.

Main research institutions

top of page

Main funding institutions

The Estonian Ministry of Education and Research is responsible for the national funding of research. The Estonian Science Foundation also provides grants for studies. The Global Fund Programme in Estonia, implemented by the National Institute for Health Development, allocated funds for different drug-related studies from 2003 to 2007. Various EU research funds have also contributed to the provision of funds for relevant studies and research.

top of page

National scientific journals

No national drug research journals are published in Estonia.

top of page

Other websites

top of page

Recent studies used for the 2013 National report

The following studies were amongst those used for the 2013 Estonian National report and could be seen as among the most relevant, recent studies in Estonia. Most of the bibliographic references can be found in the next section of this page.

  • A decline in the prevalence of injecting drug users in Estonia, 2005−2009 (Uusküla, A. et al., 2013)

top of page

2013 National report bibliography (2011 to 2013 references only)

Dontšenko I, Kerbo N, Pullmann J, Plank S, Võželevskaja N, Kutsar K. Preliminary report on an ongoing outbreak of hepatitis A in Estonia, 2011. Euro Surveill. 2011;16:19996.

National HIV and AIDS strategy report of 2011.

National HIV and AIDS strategy report of 2012.

National Strategy for Prevention of Drug Addiction until 2012, the report of 2011.

National Strategy for Prevention of Drug Addiction until 2012, the report of 2012.

Ministry of Social Affairs. Annual report of the HIV treatment council, 2012. Tallinn: Ministry of Social Affairs, 2012.

Uusküla A, Rajaleid K, Talu A, Abel-Ollo K, Des Jarlais DC. A decline in the prevalence of injecting drug users in Estonia, 2005−2009. Int J Drug Policy 2013;24:312−8.

Vorobjov S, Des Jarlais DC, Abel-Ollo K, Talu A, Rüütel K, Uusküla A. Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys. Int J Drug Policy 2013;24(2):150-5.

Vorobjov S. Prevalence of HIV infection, other infections and risk behaviour among injecting drug users in Tallinn and Kohtla-Järve, 2012. Tallinn, National Institute for Health Development, 2014. 

top of page

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 03 November 2014